A client complains of gingival hypertrophy and weight loss. The nurse knows that this patient has a history of petit mal seizures. What drug is most likely responsible for the client's pathophysiological process?
1. Phenytoin (Dilantin)
2. Ethosuximide (Zarontin)
3. Amobarbital (Amytal)
4. Gabapentin (Neurontin)
Correct Answer: 2
Rationale 1: Phenytoin (Dilantin) is not used for petit mal seizures.
Rationale 2: Ethosuximide (Zarontin) causes gingival hypertrophy, and the weight loss is due to mouth pain and the client's unwillingness to eat.
Rationale 3: Amobarbital (Amytal) does not cause these symptoms.
Rationale 4: Gabapentin (Neurontin) does not cause these symptoms.
Global Rationale: Ethosuximide (Zarontin) causes gingival hypertrophy, and the weight loss is due to mouth pain and the client's unwillingness to eat. Phenytoin (Dilantin) is not used for petit mal seizures. Amobarbital (Amytal) does not cause these symptoms. Gabapentin (Neurontin) does not cause these symptoms.
You might also like to view...
A nurse recently committed a drug error in which a patient received ten times the ordered dose of an opioid analgesic. How might the concept of respondeat superior affect the consequences of this event?
A) The nurse's employer may share some of the liability for this error B) There is partial obligation on the part of the patient to refuse unreasonable interventions C) The nurse's peers have a responsibility to oversee his or her practice D) There is no legal liability unless the patient suffers injury as a result of the nurse's actions
While reviewing a pregnant client's medical record, the nurse notes that the cervix was soft in texture and nontender during the pelvic examination. Based on this data, which would the nurse identify as a normal finding?
1. Piskacek sign. 2. Goodell sign. 3. Chadwick sign. 4. Hegar sign.
The nurse is caring for a patient who is in the recovery room following the implantation of an ICD. The patient has developed ventricular tachycardia (VT). What should the nurse assess and document?
A) ECG to compare time of onset of VT and onset of device's shock B) ECG so physician can see what type of dysrhythmia the patient has C) Patient's level of consciousness (LOC) at the time of the dysrhythmia D) Patient's activity at time of dysrhythmia
A patient newly diagnosed with breast cancer is asked to participate in a clinical trial for a new chemotherapy agent. This patient's freedom to participate or not participate in the study exercises protection of which of her human rights?
a. Right to fair treatment b. Right to self-determination c. Right to privacy and dignity d. Right to anonymity and confidentiality